Insider Sale: Chief Executive Officer at CADL sold 59,379 Shares

Tak Paul Peter, a Chief Executive Officer at Candel Therapeutics (NASDAQ: CADL), sold 59,379 shares of the company on Sep 11, 2026 for an estimated $620,891. This was a sale of approximately 34.4% of their shares of this class of stock. Following this trade, they now own 113,321 shares of this class of $CADL stock.

Candel Therapeutics Insider Trading Activity

Candel Therapeutics insiders have traded CADL stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of CADL stock by insiders over the last 6 months:

• Tak Paul Peter (Chief Executive Officer) has made 0 purchases and 2 sales selling 280,245 shares for an estimated $3,160,783.
• Barone Francesca (Chief Scientific Officer) sold 23,447 shares for an estimated $235,769.
• Tyagarajan Seshu (Chief Technology Officer) has made 0 purchases and 2 sales selling 14,000 shares for an estimated $154,151.